Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell, Circulating Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02610764
What this trial is testing

Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC

Who this might be right for
Esophageal Adenocarcinoma
University Hospital Freiburg 19
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Not applicableLooking for participantsNCT06693830
What this trial is testing

CtDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Who this might be right for
LymphomaLymphoma, B-CellDiffuse Large B Cell Lymphoma+2 more
Hua-Jay J Cherng, MD 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980222
What this trial is testing

Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Hoffmann-La Roche 46
Not applicableActive Not RecruitingNCT05133154
What this trial is testing

LIQUID BIOPSY IN Low-grade Glioma Patients

Who this might be right for
Glioma
University Hospital, Montpellier 50
Early research (Phase 1)Study completedNCT02552394
What this trial is testing

J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 10
Not applicableStudy completedNCT01173445
What this trial is testing

Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas 19
Not applicableLooking for participantsNCT04544969
What this trial is testing

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Who this might be right for
Circulating Tumor CellNasopharyngeal CarcinomaDistant Metastases.Clinical+1 more
Sun Yat-sen University 50
Not applicableActive Not RecruitingNCT05524012
What this trial is testing

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more
Jena University Hospital 40
Not applicableLooking for participantsNCT07727083
What this trial is testing

Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases

Who this might be right for
Extranodal NK/T-cell LymphomaAggressive NK-Cell LeukemiaSystemic Chronic Active Epstein-Barr Virus Disease+2 more
Rong Tao 1,500
Not applicableLooking for participantsNCT06967961
What this trial is testing

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Who this might be right for
Urothelial CarcinomaRenal CancerProstate Adenocarcinoma+7 more
Institut Claudius Regaud 450
Not applicableActive Not RecruitingNCT04770090
What this trial is testing

Research of Circulating Tumor Cells Released During Cervical Cancer Surgery

Who this might be right for
Cervical Cancer Stage IA1Cervical Cancer Stage IB1Cervical Cancer Stage IA2+1 more
University Hospital, Montpellier 200
Testing effectiveness (Phase 2)UnknownNCT03058809
What this trial is testing

Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood

Who this might be right for
Metastatic Cancer
Viatar LLC 100
Not applicableUnknownNCT03089099
What this trial is testing

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Fudan University 100
Not applicableUnknownNCT05874648
What this trial is testing

PRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early Detection

Who this might be right for
NeoplasmsCancer
Sixth Affiliated Hospital, Sun Yat-sen University 3,830
Not applicableUnknownNCT02554448
What this trial is testing

Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy

Who this might be right for
Rectal NeoplasmsCirculating Tumor Cells
Sixth Affiliated Hospital, Sun Yat-sen University 80
Not applicableLooking for participantsNCT03655015
What this trial is testing

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Who this might be right for
Lung Neoplasm
The University of Texas Health Science Center at San Antonio 150
Not applicableStudy completedNCT06408038
What this trial is testing

Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Institut Claudius Regaud 60
Not applicableStudy completedNCT06481397
What this trial is testing

OSCAR I STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ExThera Medical Corporation 5
Not applicableStudy completedNCT02608346
What this trial is testing

Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

Who this might be right for
Women With BRCA1 Germline Deleterious Mutation
Institut Curie 200
Next Page